Denovogen is a medical device company with the goal of revolutionizing minimally invasive treatments in surgical oncology. By leveraging advances in cancer therapeutics, imaging technology and computer vision, we are building a semi-autonomous robotic platform that allows physicians to remove tumours with unprecedented accuracy and precision, while sparing as much healthy tissue as possible. The first application of our technology is to treat primary and secondary liver tumours, enabling physicians to deliver the best quality of care to their patients.
| Website | https://denovogen.co/ |
| Employees | 5 (0 on RocketReach) |
| Founded | 2019 |
| Industry | Medical Devices |
| Keywords | Minimally Invasive, Surgical Oncology, Minimally Invasive Surgery, Medical Devices, Robotic Surgery, Cancer Treatment, Cancer Surgery, Computer Vision, Surgical Robotics, Precision Surgery, Oncology Technology, Medical Technology, Cancer Therapeutics, Imaging Technology, Surgical Instruments, Medical Imaging, Surgical Innovation, Healthcare Technology, Advanced Surgery |
| Competitors | Eurofins, Medpace, Covance, Celerion, Sygnature Discovery, Gladstone Institutes, Accell Clinical Research, Kymab Ltd, 北京博奥医学检验所有限公司, CRL design +31 more (view full list) |
Looking for a particular Denovogen employee's phone or email?